Navigation Links
Killer whales, blind bats, discriminating dolphins, mating birds
Date:6/25/2008

duals living in a given territory, and because existing census numbers for tigers are notably inaccurate, the group plans to develop methods to identify individual animals in the wild on the basis of the acoustic properties of their calls. The presentation will feature audio recordings of tiger calls.

Paper 4aABa7, "Acoustic communication in Panthera tigris: A study of tiger vocalization and auditory receptivity revisited" will be presented at 10:00 a.m. on Thursday, July 3 in Room 342B.


'/>"/>

Contact: Jason Bardi
jbardi@aip.org
301-209-3091
American Institute of Physics
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology news :

1. Mixing large doses of both acetaminophen painkiller and caffeine may increase risk of liver damage
2. New hope for horse lovers as effective control for killer ragwort is proposed
3. Chemistry turns killer gas into potential cure
4. Killer freeze of 07 illustrates paradoxes of warming climate
5. Killer fungus spells disaster for wheat
6. Early exposure to common weed killer impairs amphibian development
7. Scripps Oceanography Research pegs ID of red tide killer
8. Ancient protein offers clues to killer condition
9. Geisinger study: Inflammatory disease causes blindness
10. Migrating squid drove evolution of sonar in whales and dolphins, researchers argue
11. Three-way mating game of North American lizard found in distant European relative
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3